4776 - 4800 of 9036 Results
Title
Year
-
OPENTitle: DNA Sequence Analysis for Brain Disorder Using Deep Learning and Secure StorageJournal Name: Computers, Materials & ContinuaPublisher: Tech Science PressVol: 71Issue #: 3Start Page: 5949End Page: 5962Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.32604/cmc.2022.022028Best OA location URL: https://www.techscience.com/cmc/v71n3/46465/pdfCitation Count: 6
-
OPENTitle: Tailoring Motor Fluctuation Treatment: Beyond Levodopa Dose AdjustmentJournal Name: European Medical JournalPublisher: European Medical GroupVol:Issue #:Start Page: 20End Page: 27Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.33590/emj/10022165Best OA location URL: https://www.emjreviews.com/wp-content/uploads/2022/12/Tailoring-Motor-Fluctuation-Treatment-Beyond-Levodopa-Dose-Adjustment-1.pdfCitation Count: 1
-
OPENTitle: Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based ReviewJournal Name: DystoniaPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/dyst.2022.10655Best OA location URL: https://www.frontierspartnerships.org/articles/10.3389/dyst.2022.10655/pdfCitation Count: 9
-
OPENTitle: Tele-Yoga for the Management of Cervical Dystonia: A Safety and Feasibility TrialJournal Name: DystoniaPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/dyst.2021.10015Best OA location URL: https://www.frontierspartnerships.org/articles/10.3389/dyst.2021.10015/pdfCitation Count: 0
-
OPENTitle: Assessing the Quality and Reliability of COVID-19 Information on Patient Organization WebsitesJournal Name: Frontiers in CommunicationPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcomm.2021.716683Best OA location URL: https://www.frontiersin.org/journals/communication/articles/10.3389/fcomm.2021.716683/pdfCitation Count: 8
- Non-Motor Features of Parkinson’s Disease in Women2021OPENTitle: Non-Motor Features of Parkinson’s Disease in WomenJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1237End Page: 1246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-202409Citation Count: 10
- Asymmetry at Disease Onset Is Not a Predictor of Parkinson’s Disease Progression2021OPENTitle: Asymmetry at Disease Onset Is Not a Predictor of Parkinson’s Disease ProgressionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1689End Page: 1694Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-202525Citation Count: 11
-
OPENTitle: Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease: a comparison of intraoperative MRI– and MER-guided lead placementJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 134Issue #: 4Start Page: 1072End Page: 1082Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3171/2019.12.jns192010Best OA location URL: https://thejns.org/downloadpdf/journals/j-neurosurg/134/4/article-p1072.pdfCitation Count: 27
-
OPENTitle: MR-guided focused ultrasound pallidotomy for Parkinson’s disease: safety and feasibilityJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 135Issue #: 3Start Page: 792End Page: 798Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3171/2020.6.jns192773Best OA location URL: https://thejns.org/downloadpdf/journals/j-neurosurg/135/3/article-p792.pdfCitation Count: 100
- Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter Alterations2021RESTRICTEDTitle: Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter AlterationsJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 82Issue #: s1Start Page: S5End Page: S18Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-201195Citation Count: 14
- Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer’s Disease and Mild Cognitive Impairment2021RESTRICTEDTitle: Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer’s Disease and Mild Cognitive ImpairmentJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 82Issue #: 2Start Page: 541End Page: 560Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-201457Citation Count: 29
- Improving Patient Outreach by Defining Telehealth Suitability in a Tertiary Huntington’s Disease Clinic2021RESTRICTEDTitle: Improving Patient Outreach by Defining Telehealth Suitability in a Tertiary Huntington’s Disease ClinicJournal Name: Journal of Huntington's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 4Start Page: 479End Page: 484Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jhd-210498Citation Count: 5
- Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer’s Disease and Primary Tauopathy Postmortem Brains2022RESTRICTEDTitle: Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer’s Disease and Primary Tauopathy Postmortem BrainsJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 88Issue #: 1Start Page: 207End Page: 228Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-220125Citation Count: 18
- The Huntington’s Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure2022RESTRICTEDTitle: The Huntington’s Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome MeasureJournal Name: Journal of Huntington's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 2Start Page: 217End Page: 226Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jhd-210506Citation Count: 10
- How Time Rules: Diurnal Motor Patterns in de novo Parkinson’s Disease2021OPENTitle: How Time Rules: Diurnal Motor Patterns in de novo Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 2Start Page: 695End Page: 702Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-202352Citation Count: 17
- Potential Sex-Specific Effects of Apolipoprotein E ɛ4 on Cognitive Decline in Early Parkinson’s Disease2020OPENTitle: Potential Sex-Specific Effects of Apolipoprotein E ɛ4 on Cognitive Decline in Early Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 2Start Page: 497End Page: 505Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-202288Citation Count: 5
- Contribution of Basal Ganglia to the Sense of Upright: A Double-Blind Within-Person Randomized Trial of Subthalamic Stimulation in Parkinson’s Disease with Pisa Syndrome2021OPENTitle: Contribution of Basal Ganglia to the Sense of Upright: A Double-Blind Within-Person Randomized Trial of Subthalamic Stimulation in Parkinson’s Disease with Pisa SyndromeJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1393End Page: 1408Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-202388Citation Count: 7
- Serum Uric Acid in LRRK2 Related Parkinson’s Disease: Longitudinal Data from the PPMI Study2021RESTRICTEDTitle: Serum Uric Acid in LRRK2 Related Parkinson’s Disease: Longitudinal Data from the PPMI StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 2Start Page: 633End Page: 640Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-202337Citation Count: 7
- Predicting Neuropsychiatric Symptoms of Parkinson’s Disease with Measures of Striatal Dopaminergic Deficiency2021RESTRICTEDTitle: Predicting Neuropsychiatric Symptoms of Parkinson’s Disease with Measures of Striatal Dopaminergic DeficiencyJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 18Issue #: 6Start Page: 499End Page: 504Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205018666210827122133Citation Count: 4
- Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia2021OPENTitle: Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and DementiaJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 17Issue #: 13Start Page: 1214End Page: 1220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1567205018666210219105949Citation Count: 20
- Triplication of Synaptojanin 1 in Alzheimer’s Disease Pathology in Down Syndrome2022RESTRICTEDTitle: Triplication of Synaptojanin 1 in Alzheimer’s Disease Pathology in Down SyndromeJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 19Issue #: 12Start Page: 795End Page: 807Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205020666221202102832Citation Count: 4
- Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery2021RESTRICTEDTitle: Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and DiscoveryJournal Name: Current Drug Research ReviewsPublisher: Bentham Science Publishers Ltd.Vol: 13Issue #: 2Start Page: 101End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/2589977513666210211163711Citation Count: 39
- An Overview of the Active Clinical Trials for Parkinson’s Disease Psychosis2022RESTRICTEDTitle: An Overview of the Active Clinical Trials for Parkinson’s Disease PsychosisJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 165End Page: 170Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2022-0020Citation Count: 0
-
OPENTitle: Opicapone in Uk Clinical Practice: effectiveness, Safety and Cost Analysis in Patients With Parkinson’s DiseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 2Start Page: 77End Page: 91Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2217/nmt-2021-0057Best OA location URL: https://eprints.ncl.ac.uk/281877Citation Count: 9
-
RESTRICTEDTitle: Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune DisordersJournal Name: Current Chinese ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 2Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/2666001601666211126091737Best OA location URL: https://hal.science/hal-03806707Citation Count: 0